Jazz Pharmaceuticals plc
JAZZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $251,412 | -$718,470 | -$92,541 | $191,115 |
| Dep. & Amort. | $178,246 | $174,009 | $164,873 | $168,417 |
| Deferred Tax | -$271,410 | -$66,419 | -$43,833 | -$2,355 |
| Stock-Based Comp. | $0 | $64,501 | $67,653 | $0 |
| Change in WC | $130,850 | -$327,116 | $287,904 | -$79,932 |
| Other Non-Cash | $185,518 | $962,350 | $45,728 | $121,335 |
| Operating Cash Flow | $474,616 | $88,855 | $429,784 | $398,580 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$45,175 | -$12,967 | -$13,881 | -$13,287 |
| Net Acquisitions | $0 | -$858,053 | $0 | $0 |
| Inv. Purchases | -$640,125 | $440,050 | -$440,050 | -$470,000 |
| Inv. Sales/Matur. | $400,000 | $470,000 | $310,000 | $290,000 |
| Other Inv. Act. | -$42,500 | -$680,050 | -$25,000 | $0 |
| Investing Cash Flow | -$327,800 | -$641,020 | -$168,931 | -$193,287 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$7,750 | -$7,750 | -$757,750 | -$13,466 |
| Stock Issued | $733 | $10,497 | $0 | $9,196 |
| Stock Repurch. | $0 | -$125,023 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3,812 | -$2,249 | -$55,716 | -$4,005 |
| Financing Cash Flow | -$10,829 | -$124,525 | -$813,466 | -$8,275 |
| Forex Effect | -$89,797 | $4,624 | $1,695 | $37,711 |
| Net Chg. in Cash | $46,190 | -$672,066 | -$550,918 | $234,729 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,189,880 | $1,861,946 | $2,412,864 | $1,968,135 |
| End Cash | $1,236,070 | $1,189,880 | $1,861,946 | $2,202,864 |
| Free Cash Flow | $459,441 | $100,888 | $390,903 | $385,293 |